MARC details
| 000 -LEADER |
| fixed length control field |
04090cam a22003014a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
| control field |
KENaKMTC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20251028090018.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
080508s2009 nyua b 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9781420070866 |
| Qualifying information |
hbk. : alk. paper |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
142007086X |
| Qualifying information |
hbk. : alk. paper |
| 040 ## - CATALOGING SOURCE |
| Transcribing agency |
DLC |
| Modifying agency |
DLC |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
| Classification number |
RC776.O3.C47 2009 |
| 060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
| Classification number |
W1 |
| Item number |
LU62 v.228 2009 |
| 245 00 - TITLE STATEMENT |
| Title |
Chronic obstructive pulmonary disease exacerbations / |
| Statement of responsibility, etc |
edited by Jadwiga A. Wedzicha, Fernando J. Martinez. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
| Place of publication, distribution, etc |
New York : |
| Name of publisher, distributor, etc |
Informa Healthcare, |
| Date of publication, distribution, etc |
c2009. |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
xxv, 438 pages. : |
| Other physical details |
illustrations. ; |
| Dimensions |
24 cm. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 ## - FORMATTED CONTENTS NOTE |
| Formatted contents note |
CONTENTS<br/>Part I: Introduction. <br/>1. Definitions and severity of COPD exacerbations --<br/>2. Epidemiology of COPD exacerbations --<br/>3. Differential diagnosis of COPD exacerbations --<br/>PART II: Mechanisms and Pathophysiology. <br/>4. Symptom changes at exacerbations --<br/>5. Airway pathology at exacerbations --<br/>6. Airway and systemic inflammatory markers at exacerbation --<br/>7. Pathophysiology of acute exacerbations of COPD --<br/>8. Systemic consequences of COPD exacerbations --<br/>9. Mechanisms of respiratory failure at exacerbations --<br/>10. Role of respiratory viral infection at exacerbation --<br/>11. Do airway bacteria cause COPD exacerbations? --<br/>12. Interactions of airway pathogens and inflammatory processes --<br/>13. Role of co-morbidity at COPD exacerbations --<br/>14. Environmental causes of exacerbations --<br/>15. Mechanisms and pathophysiological changes in alpha-1 AT deficiency exacerbations --<br/>16. Animal models of COPD exacerbations --<br/>17. Comparison of asthma and COPD exacerbations --<br/>Part III: Impact of Exacerbations. <br/>18. Risk factors for hospital admission --<br/>19. Effect of exacerbations on disease progression and mortality --<br/>20. Health economic consequences of COPD exacerbations --<br/>Part IV: Management of the Acute Exacerbation. <br/>21. Use of bronchodilators and mucolytics at COPD exacerbations --<br/>22. Corticosteroids in the management of acute exacerbations --<br/>23. Antibiotic therapy at COPD exacerbations --<br/>24. Non invasive ventilatory support in acute exacerbations of COPD --<br/>25. Invasive ventilation and weaning at COPD exacerbation --<br/>26. Oxygen therapy at exacerbations --<br/>27. End of life issues and COPD exacerbations --<br/>28. Novel models of care for COPD exacerbations --<br/>29. Physiotherapy airway clearance at exacerbation --<br/>30. COPD exacerbation and pulmonary rehabilitation --<br/>Part V: Prevention of COPD Exacerbation. <br/>31. Pharmacological prevention of COPD exacerbations --<br/>32. Early intervention and self-management in exacerbation prevention --<br/>33. Immunological interventions --<br/>34. Home mechanical ventilation and oxygen therapy --<br/>Part VI: Issues for Studies of COPD Exacerbations. <br/>35. Design of trials for COPD exacerbations --<br/>36. Statistical considerations for COPD exacerbation trials --<br/>37. Future development in COPD exacerbations.<br/> |
| 520 ## - SUMMARY, ETC. |
| Expansion of summary note |
Chronic Obstructive Pulmonary Disease Exacerbations covers the definition, diagnosis, epidemiology, mechanisms, and treatment associated with COPD exacerbations. This text also addresses imaging and how it plays a pivotal role in the diagnosis and study of exacerbations. Written by today 's top experts, Chronic Obstructive Pulmonary Disease Exacerbations -- is formatted into separate sections covering imaging diagnosis and treatment, making this text practical and easy-to-useexamines current and breakthrough pharmacologic and non-pharmacologic treatmentsincludes COPD-causing exacerbations such as viral and bacterial infectionsdiscusses the negative environmental factors relating to COPD |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Lungs |
| General subdivision |
Diseases, Obstructive |
| -- |
Complications. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Pulmonary Disease, Chronic Obstructive. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Recurrence. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Wedzicha, Jadwiga Anna. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Martinez, Fernando J. |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
| Uniform title |
Lung biology in health and disease ; |
| Volume number/sequential designation |
v. 228. |
| 856 41 - ELECTRONIC LOCATION AND ACCESS |
| Materials specified |
Table of contents only |
| Uniform Resource Identifier |
<a href="http://www.loc.gov/catdir/toc/ecip0818/2008021270.html">http://www.loc.gov/catdir/toc/ecip0818/2008021270.html</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Books |
| Intials |
RC |